Agal.Ns
AGAL.NS is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products to industrial and construction sectors.
Business. AGAL.NS is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products to industrial and construction sectors.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
AGAL.NS is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products to industrial and construction sectors.
AGAL.NS has a debt-to-equity ratio of 0.36, indicating a relatively conservative capital structure with a strong equity base. The company's current ratio of 3.76 suggests robust short-term liquidity, as it holds more than three times the current liabilities in current assets. However, the company's net cash position is negative after subtracting total debt, which could signal potential liquidity constraints in the near term.
In terms of profitability, AGAL.NS reports a return on equity (ROE) of 16.1% and a return on assets (ROA) of 11.46%. These figures are strong and suggest that the company is effectively utilizing its equity and assets to generate returns. The operating margin, calculated as operating income divided by revenue, is approximately 36.6%, which is a key indicator of operational efficiency in the chemical industry.
AGAL.NS's revenue is primarily concentrated in the chemical manufacturing segment, with no disclosed geographic diversification. The company's exposure to a single business line and lack of geographic diversification could pose concentration risks, especially in volatile markets where demand for commodity chemicals may fluctuate.
The company's growth trajectory is not explicitly outlined in the provided data, but the capital expenditure of -136,109,000 INR suggests a reduction in investment in new projects or facilities. This could indicate a strategic shift or a response to market conditions. The operating cash flow of 147,022,000 INR and free cash flow of 35,205,000 INR provide some flexibility for the company to reinvest or return value to shareholders.
The risk assessment for AGAL.NS indicates a medium liquidity risk and a low dilution risk. The company's net cash position being negative after subtracting total debt is a key flag that could affect its liquidity. The dilution risk is low, as there is no indication of significant share issuance or dilution potential in the near term.
There are no recent events or filings mentioned in the provided data that would significantly impact the company's operations or financial position. The company's financial performance and risk profile are based on the latest available financial data, and no specific events have been disclosed that would alter the current outlook.
- AGAL.NS maintains a conservative capital structure with a debt-to-equity ratio of 0.36 and a strong current ratio of 3.76.
- The company's profitability is strong, with a return on equity of 16.1% and a return on assets of 11.46%.
- AGAL.NS's revenue is concentrated in the chemical manufacturing segment, with no geographic diversification disclosed.
- The company's capital expenditure is negative, indicating a reduction in investment, and its net cash position is negative after subtracting total debt, which could affect liquidity.
- **margin_outlook_rationale**: The company's operating margin is strong at 36.6%, indicating efficient cost management and pricing power in the chemical industry.
- **rd_outlook_rationale**: No specific R&D data is provided, but the company's focus on commodity chemicals suggests a lower R&D intensity compared to specialty chemical firms.
- **capex_outlook_rationale**: The negative capital expenditure of -136,109,000 INR suggests a strategic reduction in investment, possibly due to market conditions or a shift in priorities.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- AGAL.NS Market data — financials · 2026-05-27